Coverage and predictors of influenza vaccination in patients with cystic fibrosis in a campaign with a mobile phone text messaging intervention.
Ana Clara ZoniMaría D Esteban-VasalloMaría-Felicitas Domínguez-BerjónJuan Manuel SendraJenaro Astray-MochalesPublished in: Human vaccines & immunotherapeutics (2018)
Annual influenza vaccination is considered the best protection against influenza infection. We analyzed the influenza vaccine coverage (IVC) in cystic fibrosis (CF) patients and evaluated the factors associated with the IVC, including the effect of text-message/SMS reminders. We performed a cross-sectional study in the Community of Madrid (Spain) in 2015. The target population was people with CF older than 6 months of age at the beginning of the flu vaccination campaign. The IVC was calculated according to the study variables. A total of 445 CF patients were analyzed. In 2015, IVC reached 67.9% and was higher in children and women. The main factor associated with flu vaccination was having been vaccinated in the previous campaign (aOR 14.36; IC95%: 8.48-24.32). The probability of being vaccinated after receiving the SMS was more than twice than for those who did not receive it, although no statistical significance was reached. In conclusion the IVC of patients with CF is high, but it still has room for improvement. SMS reminders sent to CF patients might improve influenza vaccine uptake.
Keyphrases
- cystic fibrosis
- end stage renal disease
- chronic kidney disease
- ejection fraction
- inferior vena cava
- pseudomonas aeruginosa
- newly diagnosed
- prognostic factors
- healthcare
- randomized controlled trial
- type diabetes
- smoking cessation
- mental health
- patient reported outcomes
- chronic obstructive pulmonary disease
- adipose tissue
- risk factors
- middle aged
- health insurance